Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Orthofix Medical Inc.

Orthofix provides medical devices and solutions aimed at improving patient mobility through innovations in spine and orthopedic care. self-described.

msh id	COM:ORTHOFIX
symbol	OFIX
name	Orthofix Medical Inc.
homepage url	https://www.orthofix.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	1.63K
crunchbase url	-
linkedin url	-
founders	-

market cap	560.31M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.85
growth cost of revenue	1.25
growth depreciation and amortization	17.85
growth ebitda	-2.72
growth ebitda ratio	-1.3
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.81
growth gross profit	0.39
growth gross profit ratio	-0.14

COM:ORTHOFIX

Orthofix

Last Close

18.87

21/11 21:00

Market Cap

560.31M

Beta: -

Volume Today

164.56K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	888.4M
cost of revenue	888.4M
depreciation and amortization	53.06M
ebitda	-88.7M
ebitda ratio	-0.12
eps	-4.12
eps diluted	-4.12
operating expenses	610.63M
operating income	-141.76M
operating income ratio	-0.19

accounts receivables	-10.41M
capital expenditure	-62.05M
cash at beginning of period	50.7M
cash at end of period	37.76M
inventory	222.17M
working capital ttm	241.17M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-